Jin Lee | Bloomberg | Getty Images Marianne Lake, chief financial officer of JPMorgan Chase & Co. The trading environment is decidedly less exciting than it was during last year’s post-election rally, as JPMorgan Chase‘s chief financial officer points out. Revenue from sales and trading at the bank is running 15 percent lower so far
0 Comments
The age-old diversification strategy of reducing risk by moving more into bonds won’t work so well in a rising interest rate environment, as this may increase risk rather than decrease it. So, many are looking for other means of diversification. Increasingly, they’re considering alternative investments — broadly defined, anything other than stocks or bonds. The
0 Comments
There are three things that are triggering the CVS-Aetna deal and one of them is Amazon, former Aetna CEO John Rowe told CNBC on Monday. CVS Health will acquire Aetna for about $69 billion in cash and stock, the two companies announced on Sunday. The deal would combine CVS’ pharmacy business and pharmacy-benefit-manager platform (PBM)
0 Comments
While technology’s bullish run this year has many on Wall Street wondering if the sector is set to roll over, MKM Partners recommends investors buy Micron and “buy the dip.” Pointing to a 1.5 percent decline in the Technology Select Sector SPDR ETF (XLK) last week (down 1 percent Monday) and a 31 percent increase
0 Comments
“This is just the beginning,” said Eric Mancini, certified financial planner and wealth advisor with Traphagen Financial Group. “It’s only in the last couple of years we’re seeing any sustained push from [private equity] companies.” In fact, according to Bloomberg, “private equity is trying to cut out the middleman — namely, the brokers at big
0 Comments
When clients ask advisor Phillip Christenson about health-care planning, he admits he has no idea how health care will look when they’re ready to tap funds. Therefore, he runs a few different scenarios, analyzing how much they will need if health-care costs inflate by 10 percent or 15 percent or more. “There’s no real answer,
0 Comments
CVS Health is expected to announce plans to acquire Aetna for roughly $69 billion in cash and stock in a first-of-its kind deal aimed at fending off challenges in retail and health care, sources familiar with the situation told CNBC on Sunday. The landmark agreement is one of the year’s largest so far. It comes
0 Comments